Position in KYMR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$421,415,456
+$97,443,429 QoQ
Shares Held
3,675,028
-5.5% QoQ
Ownership
4.42%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#8
of 273 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 0%
Shared 90%
None 10%
Common Shares in KYMR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLINGTON MANAGEMENT GROUP LLP holds $14,994,233,945 across 206 Biotechnology names. KYMR ranks #9 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,247,658 | $1,613,209,155 | |
| 2 | ARGX |
Argenx SE
|
930,548 | $863,334,513 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,270,087 | $791,950,042 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,843,415 | $719,794,757 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,110,407 | $635,295,816 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
7,651,415 | $606,680,693 | |
| 7 | CYTK |
Cytokinetics Inc
|
6,931,770 | $590,517,483 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
825,714 | $443,367,129 |
All Filings in KYMR
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $421,415,456 | 3,675,028 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $323,972,027 | 3,889,687 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $343,370,313 | 4,412,933 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $294,076,107 | 5,195,691 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $234,436,738 | 5,372,061 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $164,134,411 | 5,996,873 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $213,513,721 | 5,307,326 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $218,586,929 | 4,618,359 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $128,635,736 | 4,309,405 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $172,606,617 | 4,293,697 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $122,604,102 | 4,815,558 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $67,044,269 | 4,823,329 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $110,873,479 | 4,822,683 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $127,142,860 | 4,291,018 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $114,593,577 | 4,591,089 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $74,244,100 | 3,410,386 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $99,137,965 | 5,034,940 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $136,513,694 | 3,225,749 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $171,093,737 | 2,694,814 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $144,966,498 | 2,467,935 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $40,155,137 | 827,941 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $26,008,723 | 669,293 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $104,815,898 | 1,690,579 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $57,000,784 | 1,764,184 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||